Kulkarni Samarth Insider Trading
Get the latest insider transactions of Kulkarni Samarth. Kulkarni Samarth is Chief Business Officer in CRISPR Therapeutics AG ($CRSP) and Chief Executive Officer in CRISPR Therapeutics AG ($CRSP) and Please See Remarks in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Repare Therapeutics Inc. ($RPTX). Discover the current value of Kulkarni Samarth shares.
Address: C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY ST. CAMBRIDGE 02139MA
Kulkarni Samarth is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | Chief Executive Officer, Please See Remarks, Chief Business Officer | 217,719 | 3,429,074.25 |
| BDTX | Black Diamond Therapeutics, Inc. | Director | 0 | |
| RPTX | Repare Therapeutics Inc. | Director | 0 |
Insider Trading Transactions of Kulkarni Samarth
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | BDTX | Black Diamond Therapeutic ... | Kulkarni Samarth | Director | Option Exercise | 12.55 | 15,000 | 188,250 | 15,000 |
| Jun 17 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 12.57 | 30,000 | 377,100 | 217,719 |
| Jun 17 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 125.39 | 10,383 | 1,301,924 | 207,336 |
| Jun 17 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 126.86 | 16,129 | 2,046,125 | 191,207 |
| Jun 17 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 127.51 | 3,488 | 444,755 | 187,719 |
| Jun 17 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 12.57 | 30,000 | 377,100 | 63,333 |
| May 14 2021 | RPTX | Repare Therapeutics Inc. | Kulkarni Samarth | Director | Option Exercise | 32.44 | 21,000 | 681,240 | 21,000 |
| Apr 23 2021 | BDTX | Black Diamond Therapeutic ... | Kulkarni Samarth | Director | Option Exercise | 24.33 | 14,921 | 363,028 | 14,921 |
| Apr 23 2021 | BDTX | Black Diamond Therapeutic ... | Kulkarni Samarth | Director | Option Exercise | 24.33 | 14,921 | 363,028 | 14,921 |
| Mar 12 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 0.00 | 11,833 | 0 | 194,024 |
| Mar 12 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 124.15 | 5,526 | 686,053 | 188,498 |
| Mar 12 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 133.88 | 100,000 | 13,388,000 | 100,000 |
| Mar 12 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 0.00 | 36,000 | 0 | 36,000 |
| Mar 03 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 130.25 | 798 | 103,940 | 182,191 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 20,000 | 36,200 | 202,989 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 211.83 | 3,140 | 665,146 | 199,849 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 212.75 | 6,525 | 1,388,194 | 193,324 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 213.71 | 5,623 | 1,201,691 | 187,701 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 214.68 | 1,700 | 364,956 | 186,001 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 216.50 | 1,708 | 369,782 | 184,293 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 217.44 | 1,304 | 283,542 | 182,989 |
| Jan 20 2021 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 20,000 | 36,200 | 108,983 |
| Dec 30 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 13,800 | 24,978 | 182,989 |
| Dec 30 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 13,800 | 24,978 | 128,983 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 20,000 | 36,200 | 189,189 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 141.17 | 5,500 | 776,435 | 183,689 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 141.98 | 5,034 | 714,727 | 178,655 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 142.75 | 6,766 | 965,847 | 171,889 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 143.71 | 2,100 | 301,791 | 169,789 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 144.97 | 600 | 86,982 | 169,189 |
| Dec 11 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 20,000 | 36,200 | 142,783 |
| Dec 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 129.58 | 779 | 100,943 | 169,189 |
| Oct 06 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 86.75 | 47,333 | 4,106,138 | 47,333 |
| Sep 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 94.15 | 779 | 73,343 | 169,968 |
| Sep 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 94.15 | 779 | 73,343 | 169,968 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 17,275 | 31,268 | 188,801 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 63.57 | 2,400 | 152,568 | 186,401 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 64.61 | 9,300 | 600,873 | 177,101 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 65.26 | 5,575 | 363,825 | 171,526 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 66.26 | 779 | 51,617 | 170,747 |
| Jun 03 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 17,275 | 31,268 | 162,783 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 4,307 | 7,796 | 175,833 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 65.16 | 4,307 | 280,644 | 171,526 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 10,693 | 19,354 | 182,219 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 65.28 | 10,693 | 698,039 | 171,526 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 4,307 | 7,796 | 190,751 |
| May 21 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 10,693 | 19,354 | 180,058 |
| Mar 04 2020 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 52.74 | 794 | 41,876 | 171,526 |
| Dec 18 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 8,000 | 14,480 | 172,320 |
| Dec 18 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 8,000 | 14,480 | 195,058 |
| Dec 05 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 0.00 | 120,000 | 0 | 120,000 |
| Dec 02 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 71.65 | 741 | 53,093 | 164,320 |
| Sep 03 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 46.21 | 740 | 34,195 | 165,061 |
| Jun 19 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 20,000 | 36,200 | 185,801 |
| Jun 19 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 46.00 | 20,000 | 920,000 | 165,801 |
| Jun 19 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 20,000 | 36,200 | 203,058 |
| Jun 04 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 35.57 | 741 | 26,357 | 165,801 |
| May 01 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 20,000 | 36,200 | 186,542 |
| May 01 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 42.03 | 20,000 | 840,600 | 166,542 |
| May 01 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 20,000 | 36,200 | 223,058 |
| Mar 07 2019 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 40.87 | 250,000 | 10,217,500 | 250,000 |
| Dec 11 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 21,500 | 38,915 | 167,290 |
| Dec 11 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 21,500 | 38,915 | 243,058 |
| Dec 03 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 38.33 | 741 | 28,403 | 145,790 |
| Sep 04 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 56.67 | 741 | 41,992 | 146,531 |
| Jun 15 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 59.31 | 109,000 | 6,464,790 | 109,000 |
| Jun 15 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 59.31 | 109,000 | 6,464,790 | 109,000 |
| Jun 05 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 15,000 | 27,150 | 163,560 |
| Jun 05 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 67.28 | 4,600 | 309,488 | 158,960 |
| Jun 05 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 70.28 | 10,400 | 730,912 | 148,560 |
| Jun 05 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Sell | 67.13 | 741 | 49,743 | 147,819 |
| Jun 05 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 15,000 | 27,150 | 264,558 |
| Apr 18 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 19.12 | 75,000 | 1,434,000 | 150,000 |
| Apr 18 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 19.12 | 75,000 | 1,434,000 | 150,000 |
| Mar 14 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 19.12 | 75,000 | 1,434,000 | 75,000 |
| Mar 09 2018 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 51.49 | 136,000 | 7,002,640 | 136,000 |
| Dec 26 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 1.81 | 15,000 | 27,150 | 148,560 |
| Dec 26 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 1.81 | 15,000 | 27,150 | 279,558 |
| Dec 05 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Buy | 19.12 | 26,667 | 509,873 | 133,560 |
| Dec 05 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Executive Offic ... | Option Exercise | 19.12 | 260,000 | 4,971,200 | 260,000 |
| Aug 30 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 20.09 | 23,154 | 465,162 | 110,893 |
| Aug 30 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 20.00 | 4,000 | 80,000 | 106,893 |
| May 05 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Please See Remarks | Option Exercise | 16.21 | 100,000 | 1,621,000 | 100,000 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 3,275 | 5,928 | 137,322 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 16.74 | 3,275 | 54,816 | 134,047 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 2,206 | 3,993 | 136,253 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 16.78 | 2,206 | 37,023 | 134,047 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 3,275 | 5,928 | 296,764 |
| Apr 28 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 2,206 | 3,993 | 294,558 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 3,000 | 5,430 | 137,047 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 17.01 | 3,000 | 51,033 | 134,047 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 3,500 | 6,335 | 137,547 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 16.46 | 3,500 | 57,619 | 134,047 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 5,115 | 9,258 | 139,162 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 16.87 | 5,115 | 86,290 | 134,047 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 3,000 | 5,430 | 308,654 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 3,500 | 6,335 | 305,154 |
| Apr 25 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 5,115 | 9,258 | 300,039 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 7,258 | 13,137 | 141,305 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 17.54 | 4,809 | 84,361 | 136,496 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 18.54 | 2,449 | 45,393 | 134,047 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Buy | 1.81 | 2,800 | 5,068 | 136,847 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Sell | 17.36 | 2,800 | 48,621 | 134,047 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 7,258 | 13,137 | 314,454 |
| Apr 21 2017 | CRSP | CRISPR Therapeutics AG | Kulkarni Samarth | Chief Business Office ... | Option Exercise | 1.81 | 2,800 | 5,068 | 311,654 |